BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31774189)

  • 1. Total plasma volume determinations for patients with potentially challenging conditions requiring therapeutic plasma exchange: Dealer's choice.
    Rosenbaum L; Johnson M; Li M; Raval JS
    J Clin Apher; 2020 Apr; 35(2):138-139. PubMed ID: 31774189
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic Plasmapheresis: A Revision of Literature.
    Altobelli C; Anastasio P; Cerrone A; Signoriello E; Lus G; Pluvio C; Perna AF; Capasso G; Simeoni M; Capolongo G
    Kidney Blood Press Res; 2023; 48(1):66-78. PubMed ID: 36481657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines.
    Winters JL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():7-12. PubMed ID: 23233554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasma exchange - A brief review of indications, urgency, schedule, and technical aspects.
    Pham HP; Staley EM; Schwartz J
    Transfus Apher Sci; 2019 Jun; 58(3):237-246. PubMed ID: 31085053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis.
    Schmidt JJ; Asper F; Einecke G; Eden G; Hafer C; Kielstein JT
    BMC Nephrol; 2018 Jan; 19(1):12. PubMed ID: 29334938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate.
    Mathur G; Collins L; Tigges CR; Schlueter AJ
    Transfus Apher Sci; 2018 Apr; 57(2):201-203. PubMed ID: 29439919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic principles of therapeutic plasma exchange.
    Weinstein R
    Transfus Apher Sci; 2023 Apr; 62(2):103675. PubMed ID: 36849322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a national on-line registry for apheresis in Korea.
    Song EY; Yoon JH; Lee JW; Park CW; Kwon SW; Kim DW; Lim YA; Kim HO; Han KS
    Transfus Apher Sci; 2008 Apr; 38(2):93-100. PubMed ID: 18359274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma exchange in patients with severe obesity (BMI >40): A survey of practices in the United States.
    Babariya SP; Vivero A; Peedin A; Karp JK
    J Clin Apher; 2021 Dec; 36(6):802-807. PubMed ID: 34355813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TERMINOLOGY OF THE PROCEDURES OF DRAWING BLOOD AND RECEIVING IT COMPONENTS].
    Timchenko AS; Smiyanov VA; Lyubchack VP; Lyubchack VV
    Lik Sprava; 2015; (5-6):140-3. PubMed ID: 27089732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature.
    Ellis J; Theodossiou C; Schwarzenberger P
    Am J Med Sci; 1999 Sep; 318(3):190-3. PubMed ID: 10487410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Future and limits of immunohemotherapy. Great possibilities with apheresis].
    Norda R; Lundkvist I; Söderström T
    Lakartidningen; 1995 Jan; 92(3):155-60. PubMed ID: 7837849
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjustment by hematocrit level in calculation of removal rate in therapeutic apheresis.
    Sakurasawa T; Ohkubo A; Hoshikawa Y; Yamauchi D; Yamamoto H; Seshima H; Kurashima N; Iimori S; Rai T; Uchida S; Naito S
    Ther Apher Dial; 2021 Aug; 25(4):425-431. PubMed ID: 33887113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional apheresis therapies: a review.
    Ward DM
    J Clin Apher; 2011; 26(5):230-8. PubMed ID: 21882233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrift in the world of therapeutic apheresis: One center's experience in using arterio-venous fistulas during apheresis procedures.
    Larson J
    Transfus Apher Sci; 2016 Oct; 55(2):264-265. PubMed ID: 27663069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature.
    Cook MK; Malkin M; Karafin MS
    J Clin Apher; 2015 Jun; 30(3):188-92. PubMed ID: 25116126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.